Question 1

Does Qube Research & Technologies own CYPH stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Qube Research & Technologies holds 15,742 shares of CYPH (Leap Therapeutics), worth $9,639.

Question 2

How many shares of CYPH does Qube Research & Technologies own?

Accepted Answer

As of its Q2 2026 13F, Qube Research & Technologies holds 15,742 shares of CYPH (Leap Therapeutics).

Question 3

What is Qube Research & Technologies' CYPH position worth?

Accepted Answer

As of its Q2 2026 13F, Qube Research & Technologies' CYPH position is worth $9,639.

Question 4

Is Qube Research & Technologies buying or selling CYPH?

Accepted Answer

In Q2 2026, Qube Research & Technologies opened a new CYPH position of 15,742 shares.

Question 5

When did Qube Research & Technologies first buy CYPH?

Accepted Answer

Qube Research & Technologies first reported CYPH in its Q4 2023 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	15,742	—	$9,639	0.0%	$0.61	26
2026-Q1	Exited	0	-100.0%	$0	0.0%	$0.80	0
2025-Q4	New	62,486	—	$72,484	0.0%	$1.16	29
2024-Q3	Exited	0	-100.0%	$0	0.0%	$2.57	0